Citius Pharmaceuticals is trading 13.14% up at $0.46, with no clear company-specific announcement identified for October 26.
- The latest located company news was its October 12 investor-conference notice.
- U.S. shares edged higher as oil eased and investors looked ahead to earnings and central-bank meetings, including the Federal Reserve. The backdrop may be supportive but does not establish a direct cause for the stock’s gain.